Clindamycin phosphate 24729-96-2 Antibiotic
Intlawulo:T/T, L/C
Imvelaphi yeMveliso:eTshayina
Indawo yokuthumela ngenqanawa:Beijing/Shanghai/Hangzhou
Umthamo wemveliso:800kg/ngenyanga
Umyalelo(MOQ):25kg
Ixesha lokukhokhela:Iintsuku zokusebenza ezi-3
Imeko yokugcina:Igcinwe kwindawo epholileyo neyomileyo, ivalwe kwaye igcinwe kude nokukhanya.
Ipakethe imathiriyeli:igubu
Ubungakanani bepakethi:25kg/igubu
Ulwazi ngokhuseleko:Ayizompahla eziyingozi
Intshayelelo
I-Clindamycin phosphate yikhemikhali ye-semi-synthetic ephuma kwi-clindamycin, emhlophe okanye emhlophe-mhlophe icrystalline powder kwiqondo lobushushu begumbi, ayinavumba, iyakrakra kwincasa, kunye nehygroscopic.Ayinamsebenzi we-antibacterial kwi-vitro, kwaye inokuthi ifakwe ngokukhawuleza i-hydrolyzed kwi-clindamycin emva kokungena emzimbeni ukuze yenze iziphumo ze-pharmacological.Indlela yokusebenza kwayo, i-antibacterial spectrum, izibonakaliso, kunye neziphumo zonyango ziyafana nezo ze-clindamycin.
Inkcazo (USP43)
| Into | Inkcazo |
| Imbonakalo | Imhlophe ukuya kumhlophe, i-hygroscopic, i-crystalline powder.Ayinavumba okanye ayinavumba, kwaye inencasa ekrakra. |
| Ukunyibilika | Inyibilika simahla emanzini, ayinyibiliki kwi-ethanol, kwi-acetone, kwi-chloroform, kwibenzene, nakwi-inether. |
| Ukuchongwa | A.IR |
| B: Ixesha lokugcinwa kwencopho enkulu yesisombululo sesampulu ihambelana nesisombululo esisemgangathweni njengoko sifunyenwe kwi-assay. | |
| Ubukhazikhazi | Uyahlangabezana neemfuno |
| PH | 3.5~4.5 |
| Amanzi | ≤6.0% |
| I-endotoxin yebhaktheriya | <0.581U/mg |
| Izinto ezinxulumeneyo | Lincomycin phosphate ≤1.0% |
| I-Lincomycin ≤0.5% | |
| Clindamycin B phosphate ≤1.5% | |
| 7-epiclindamycin phosphate ≤0.8% | |
| Clindamycin 3-phosphate ≤0.3% | |
| Clindamycin ≤0.5% | |
| Nawuphi na umntu ongachazwanga ukungcola ≤1.0% | |
| Ubumdaka bubonke ≤4.0% | |
| Izinyibilikisi ezishiyekileyo | I-Ethanol≤5000ppm I-acetone ≤5000ppm I-Chloroform≤60ppm I-Pyridine≤200ppm IMethanol≤1000ppm |
| Isivavanyi | ≥780μg/mg |
